Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial.

Source:http://linkedlifedata.com/resource/pubmed/id/15963389

J. Am. Coll. Cardiol. 2005 Jun 21 45 12 1932-8

Download in:

View as

Triples

General Info

PMID
15963389